CSRxP LAUNCHES SEVEN-FIGURE “PROMISE” CAMPAIGN URGING CONGRESS TO HOLD BIG PHARMA ACCOUNTABLE
Feb 4, 2020
Comprehensive Effort Will Target D.C., In Addition To Nine Presidential &… Read More
© 2024 CSRXP- All Rights Reserved
Press & Statements
CSRxP: SOTU 2020 OFFERS PRESIDENT UNIQUE MOMENT TO LEAD ON LOWERING Rx PRICES
Feb 3, 2020
Trump Can Use Platform To Demand Congress Hold Big Pharma Accountable &… Read More
CSRXP APPLAUDS SENATE PASSAGE OF USMCA THAT PUTS AMERICAN PATIENTS FIRST
Jan 16, 2020
Lawmakers Hold Strong, Advance Trade Deal Without Big Pharma-Backed Provision… Read More
CSRXP: BIG PHARMA THUMBS ITS NOSE AT STRUGGLING AMERICANS WITH NEW YEAR PRICE HIKES
Jan 2, 2020
Drug Makers, Including Brand Name Giants Like Pfizer, Increase Prices on More… Read More
CSRXP APPLAUDS INCLUSION OF CREATES IN SPENDING DEAL; URGES CONGRESS TO KEEP WORKING TO HOLD BIG PHARMA ACCOUNTABLE, LOWER Rx PRICES
Dec 16, 2019
Passage of Bipartisan, Market-based CREATES Act Will Be A First Step in the… Read More
CSRXP: THE HOUSE HAS ACTED, TIME FOR SENATE TO DO ITS JOB
Dec 12, 2019
Passage of HR3 Adds to Momentum to Hold Big Pharma Accountable; Now Congress… Read More
CSRXP APPLAUDS USMCA CHANGES TO PUT AMERICAN PATIENTS FIRST
Dec 10, 2019
Revisions to Historic Trade Deal Remove Big Pharma Carveout Washington… Read More
CSRXP ANALYSIS: BIG PHARMA SPENT TAX WINDFALL ON PROFITS, NOT R&D
Dec 10, 2019
Corporate Filings Show Drug Makers Boosted Payouts for Shareholders 17 Times… Read More
CSRXP SENATE BATTLEGROUND POLL: VOTERS BACK GRASSLEY-WYDEN, DEMAND ACTION TO HOLD BIG PHARMA ACCOUNTABLE
Nov 22, 2019
Survey Finds Overwhelming Majorities of Swing State Voters Blame Drug Makers… Read More
CSRxP: Policymakers Must Remove Big Pharma Carveout in USMCA
Oct 23, 2019
Washington Can Put Patients First By Amending Trade Provision That Would… Read More
CSRXP URGES HOUSE LAWMAKERS TO CONTINUE WORKING ACROSS PARTY LINES TO HOLD BIG PHARMA ACCOUNTABLE
Oct 16, 2019
Trio of Committee Proceedings on Drug Pricing Offer Chance to Focus on Areas… Read More
CSRxP Urges E&C Lawmakers to Continue Building Bipartisan Consensus
Sep 23, 2019
Hearing on Drug Pricing Proposals an Opportunity for Focus on Areas of… Read More